Nicotine modulation of information processing is not limited to input (attention) but extends to output (intention).

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The aim of the study was to determine the relative behavioral and functional effects of nicotine on dissociable aspects of information processing (i.e., selective attention and motor intention).

Why It Was Studied

Nicotine influences many cognitive processes, especially those requiring high attentional loads, yet the impact of nicotine on all aspects of information processing has not been well delineated.

Who Took Part

By PubMed's age tags, the people studied were young adults and adults, both men and women.

Adult smokers (N = 25) and healthy controls (N = 23) performed the intention/attention task (IAT) twice, during functional magnetic resonance imaging.

Controls were also scanned twice, with no patch placement in either session.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

A placebo (an inactive look-alike) gave the Therapeutic nicotine (patch, non-peptide) group a baseline to be compared against.

The IAT assesses the relative differences in performance evoked by prime stimuli that provide information regarding either the correct hand with which to respond (i.e., intentional primes) or the likely location of a target stimulus (i.e., attentional primes).

The order of nicotine and placebo sessions was randomized and counter-balanced.

What Was Measured

The subject headings attached to it are Administration, Cutaneous, Attention, Brain, Case-Control Studies, Intention, Magnetic Resonance Imaging and Mental Processes.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2010 (Psychopharmacology), a journal based in Germany.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.